Status:
COMPLETED
Alternative Risk Markers in Coronary Artery Disease (ARMCAD)
Lead Sponsor:
Monash University
Collaborating Sponsors:
Royal Brompton & Harefield NHS Foundation Trust
IM Medical Ltd, Melbourne
Conditions:
Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
Estimating the risk of future cardiovascular events such as death, stroke and myocardial infarction using traditional risk factors (such as age, gender, smoking, diabetes, hyperlipidaemia and hyperten...
Detailed Description
A number of variables including clinical, biochemical, and enzymatic have been evaluated to see if they add to conventional "risk-reduction" models such as Framingham and if so, to understand if they ...
Eligibility Criteria
Inclusion
- Adults (18 years or older)
- Male or Female
Exclusion
- Acute coronary syndrome
- Urgent angiography
- Assessment would constitute harm to patient
- Informed consent not obtained
Key Trial Info
Start Date :
October 1 2006
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
May 1 2016
Estimated Enrollment :
665 Patients enrolled
Trial Details
Trial ID
NCT00403351
Start Date
October 1 2006
End Date
May 1 2016
Last Update
September 2 2020
Active Locations (4)
Enter a location and click search to find clinical trials sorted by distance.
1
Box Hill Hospital (Eastern Health)
Box Hill, Victoria, Australia, 3128
2
Caulfield General Medical Centre
Caulfield, Victoria, Australia
3
Northern Hospital (Northern Health)
Epping, Victoria, Australia, 3076
4
Alfred Hospital
Melbourne, Victoria, Australia, 3004